A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome

Condition:   Rett Syndrome Intervention:   Genetic: NGN-401 Sponsor:   Neurogene Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials